Seer (SEER) Inventory Average (2021 - 2026)
Seer (SEER) posted quarterly Inventory Average of $7.9 million for Q1 2026, up 9.43% year-over-year from $7.3 million in Q1 2025, and little changed quarter-over-quarter from $8.0 million in Q4 2025.
Seer (SEER) Inventory Average (2021 - 2026) Analysis & Trends
Seer's Inventory Average history runs 6 years deep, the most recent figure standing at $7.9 million for Q1 2026.
- In Q1 2026, Inventory Average rose 9.43% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (up 9.43% YoY), while the FY2025 annual figure was $7.6 million, up 27.7% from the prior year.
- Inventory Average for Q1 2026 stood at $7.9 million, roughly flat from $8.0 million in the prior quarter.
- The five-year high for Inventory Average was $8.0 million in Q4 2025, with the low at $3.8 million in Q1 2022.
- The 5-year median for Inventory Average is $6.4 million (2022), against an average of $6.1 million.
- The sharpest annual moves came in 2022 and 2023: Inventory Average jumped 267.83% in 2022, then slipped 25.61% in 2023.
- Seer's Inventory Average stood at $5.3 million in 2022, then slipped by 17.33% to $4.4 million in 2023, then jumped by 64.88% to $7.2 million in 2024, then rose by 10.79% to $8.0 million in 2025, then declined by 0.3% to $7.9 million in 2026.
- Business Quant data shows SEER's Inventory Average at $7.9 million in Q1 2026, $8.0 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 7.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.87 Mn |
| Mar 31, 2026 | 7.94 Mn |
| Dec 31, 2025 | 7.96 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Dec 31, 2024 | 7.19 Mn |
| Sep 30, 2024 | 7.26 Mn |
| Jun 30, 2024 | 6.70 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 4.74 Mn |
| Jun 30, 2023 | 4.49 Mn |
| Mar 31, 2023 | 4.17 Mn |
| Dec 31, 2022 | 5.27 Mn |
| Sep 30, 2022 | 6.38 Mn |
| Jun 30, 2022 | 5.19 Mn |
| Mar 31, 2022 | 3.85 Mn |
| Dec 31, 2021 | 3.35 Mn |
| Sep 30, 2021 | 2.61 Mn |